Searchable abstracts of presentations at key conferences in endocrinology

ea0073aep280 | Diabetes, Obesity, Metabolism and Nutrition | ECE2021

Effects of Glucagon-Like-Peptide-1 analogue treatment in genetic obesity

Welling Mila , Groot Cornelis de , Kleinendorst Lotte , Bibian van der Voorn , Burgerhart Jansteven , Eline van der Valk , Haelst Mieke van , Erica van den Akker , Rossum Elisabeth van

IntroductionObesity is highly prevalent, comes with serious health burden and is difficult to treat. In a minority, there is a genetic cause for the obesity. In these patients, therapy-resistant obesity is often observed despite intensive lifestyle treatment. Moreover, it is still unclear whether bariatric surgery is less successful in genetic obesity. Liraglutide is a Glucagon-Like-Peptide-1 (GLP-1) receptor agonist or GLP-1 analogue, showing positive e...